Results 21 to 30 of about 10,314 (165)

Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. [PDF]

open access: yesPLoS Pathogens, 2006
Anthrax toxin receptors 1 and 2 (ANTXR1 and ANTXR2) have a related integrin-like inserted (I) domain which interacts with a metal cation that is coordinated by residue D683 of the protective antigen (PA) subunit of anthrax toxin. The receptor-bound metal
Heather M Scobie   +8 more
doaj   +3 more sources

The Receptors that Mediate the Direct Lethality of Anthrax Toxin

open access: yesToxins, 2012
Tumor endothelium marker-8 (TEM8) and capillary morphogenesis protein-2 (CMG2) are the two well-characterized anthrax toxin receptors, each containing a von Willebrand factor A (vWA) domain responsible for anthrax protective antigen (PA) binding ...
Stephen H. Leppla   +3 more
doaj   +2 more sources

Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment. [PDF]

open access: yesPLoS ONE, 2012
Soluble receptor decoy inhibitors, including receptor-immunogloubulin (Ig) fusion proteins, have shown promise as candidate anthrax toxin therapeutics.
Diane Thomas   +5 more
doaj   +2 more sources

Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. [PDF]

open access: yesPLoS ONE, 2020
Understanding immune responses to native antigens in response to natural infections can lead to improved approaches to vaccination. This study sought to characterize the humoral immune response to anthrax toxin components, capsule and spore antigens in ...
Eric K Dumas   +13 more
doaj   +2 more sources

Anthrax Toxin Characterization

open access: yesActa Medica, 2002
The anthrax toxin comprises three proteins. When they work together, they can kill humans, especially after spores of the bacteria have been inhaled.
Jiří Patočka, Miroslav Špliňo
doaj   +2 more sources

Anthrax lethal toxin exerts potent metabolic inhibition of the cardiovascular system

open access: yesMBio
Bacillus anthracis causes anthrax through a combination of bacterial infection and toxemia. As a major virulence factor of B. anthracis, anthrax lethal toxin (LT) is a zinc-dependent metalloproteinase, exerting its cytotoxicity through proteolytic ...
Zehua Zuo, Rasem Fattah, Toren Finkel
exaly   +3 more sources

What Is Anthrax?

open access: yesPathogens, 2022
Anthrax has been feared for its high mortality in animals and humans for centuries. The etiologic agent is considered a potentially devastating bioweapon, and since 1876―when Robert Koch demonstrated that Bacillus anthracis caused anthrax―it has been ...
William A. Bower   +6 more
doaj   +1 more source

Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors. [PDF]

open access: yesPLoS ONE, 2011
Anthrax toxin is the major virulence factor produced by Bacillus anthracis. The toxin consists of three protein subunits: protective antigen (PA), lethal factor, and edema factor.
Chenguang Cai   +8 more
doaj   +1 more source

Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. [PDF]

open access: yesPLoS ONE, 2008
The role of the cellular protein LRP6 in anthrax toxin entry is controversial. Previous studies showed that LRP6 was important for efficient intoxication of human M2182 prostate carcinoma cells but other studies performed with cells from gene-knockout ...
Patricia L Ryan, John A T Young
doaj   +1 more source

A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines. [PDF]

open access: yesPLoS ONE, 2016
Several different human vaccines are available to protect against anthrax. We compared the human adaptive immune responses generated by three different anthrax vaccines or by previous exposure to cutaneous anthrax.
Thomas R Laws   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy